Q32 Bio (QTTB) Invested Capital (2017 - 2026)

Q32 Bio's Invested Capital history runs 10 years deep, the most recent figure standing at $52.6 million for Q1 2026.

• In Q1 2026, Invested Capital rose 8009.88% year-over-year to $52.6 million; the TTM figure through Mar 2026 stood at $52.6 million (up 8009.88% YoY), while the FY2025 annual figure was $48.2 million, up 450.03% from the prior year.
• Invested Capital was $52.6 million for Q1 2026 at Q32 Bio, up from $48.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $266.3 million in Q1 2022 to a low of -$182.0 million in Q4 2023.
• Historically, Invested Capital has averaged $9.6 million across 5 years, with a median of $8.8 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Invested Capital sank 177.05% in 2022, then jumped 8009.88% in 2026.
• A 5-year view of Invested Capital shows it stood at -$130.7 million in 2022, then sank by 39.27% to -$182.0 million in 2023, then jumped by 104.82% to $8.8 million in 2024, then jumped by 450.03% to $48.2 million in 2025, then rose by 8.92% to $52.6 million in 2026.
• The last three Invested Capital figures came in at $52.6 million (Q1 2026), $48.2 million (Q4 2025), and -$12.2 million (Q3 2025), per Business Quant data.